Jazz Pharmaceuticals (JAZZ) Acquisitions (2012 - 2014)
Jazz Pharmaceuticals (JAZZ) posted quarterly Acquisitions of $828.7 million for Q1 2014, up 32.74% quarter-over-quarter from $624.3 million in Q2 2012.
Powered by 
Analysis
Jazz Pharmaceuticals (JAZZ) Acquisitions (2012 - 2014) Analysis & Trends
Jazz Pharmaceuticals' Acquisitions history runs 2 years deep, the most recent figure standing at $828.7 million for Q1 2014.
- In Q1 2014, Acquisitions changed N/A year-over-year to $828.7 million; the TTM figure through Dec 2014 stood at $828.7 million (changed N/A YoY), while the FY2021 annual figure was $6.2 billion, changed N/A from the prior year.
- Acquisitions for Q1 2014 stood at $828.7 million, up from $624.3 million in the prior quarter.
- The five-year high for Acquisitions was $828.7 million in Q1 2014, with the low at -$81.8 million in Q1 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Jazz Pharmaceuticals | 15.60 Bn | 13.98 Bn | 1.09 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2014 | 828.68 Mn |
| Jun 30, 2012 | 624.28 Mn |
| Mar 31, 2012 | -81.75 Mn |